Trade Recursion Pharmaceuticals, Inc. - RXRX CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.03
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.022262 %(-$0.45)Trade size with leverage ~ $2,000.00Money from leverage ~ $$1,000.00Go to platform: -0.02226%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position0.00004 %($0.00)Trade size with leverage ~ $2,000.00Money from leverage ~ $$1,000.00Go to platform: 0.00004%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.022262 %
  (-$0.45)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: 0.00004 %
  ($0.00)

Key Stats

• Prev. Close: 3.73
• Open: 3.68
• 1-Year Change: -21.37%
• Day's Range: 3.66 - 3.81

Trade Recursion Pharmaceuticals, Inc. - RXRX

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. It consists of three parts: Infrastructure Layer, The Recursion Data Universe and The Recursion Map. Its programs include REC-4881, REC-3599, REC-2282, REC-994, lead molecules for the treatment of C. difficile Colitis, lead molecules for the treatment of Neuroinflammation, lead molecules for the treatment of Batten Disease and lead molecules for the treatment of CMT2A.

Trade Recursion Pharmaceuticals, Inc. (RXRX) CFDs

Recursion Pharmaceuticals, Inc. (ticker: RXRX) is a publicly traded company listed on a major stock exchange and available to trade as a contract for difference (CFD) on Capital.com. With CFDs, you can speculate on the price movements of Recursion Pharmaceuticals, Inc. without owning the underlying shares. This means you can trade in either direction – rising or falling – depending on your outlook.*

Traders often follow the Recursion Pharmaceuticals, Inc. stock price today to stay informed about short-term market movements.

*CFDs are traded on margin, leverage amplifies both profits and losses.

Recursion Pharmaceuticals, Inc. price today

The share is quoted in $ and is currently trading around 3.71. This reflects the current Recursion Pharmaceuticals, Inc. stock price available on the market.

Live price overview

Here’s an overview of the current Recursion Pharmaceuticals, Inc. stock price and its recent trading ranges.

• Daily range: 3.65 – 3.82
• Daily movement: -0.03 (-0.8021%)
• Weekly range: 3.6 – 4.13
• Monthly range: 3.08 – 4.13
• Yearly range: 2.75 – 7.15

Why trade CFDs on the price of Recursion Pharmaceuticals, Inc. stock with Capital.com?

Capital.com provides a technology-driven trading experience that supports informed decision-making.

Advanced charting & analysis

Use interactive tools to study the Recursion Pharmaceuticals, Inc. stock price chart in detail.

• Access 100 technical indicators
• Choose from 12 chart types
• Analyse fast, intuitive charts powered by industry-leading tools

Wide market offering

Join over 880,000 global traders and explore more than:

• 4,500 stock CFDs
• 65 commodity CFDs
• 35 index CFDs
• 120 forex pairs
• 450 crypto CFDs

Powerful, user-rated platforms

• TradingView rating: 4.6
• App Store rating: 4.7
• Google Play rating: 4.6
• Trustpilot score: 4.6

What influences the price of Recursion Pharmaceuticals, Inc.?

The Recursion Pharmaceuticals, Inc. (RXRX) stock price may be influenced by a range of factors, including:

• Company earnings and financial performance
• Sector trends and industry developments
• Macroeconomic conditions, interest rates, and market sentiment
• Regulatory or geopolitical events affecting the company
• Broader stock-market volatility

These factors can increase price movement in either direction, which can create potential opportunities and potential risks for CFD traders.

Recursion Pharmaceuticals, Inc. stock forecasts

Recursion Pharmaceuticals, Inc. stock forecasts often draw on recent news, company updates, and broader market trends rather than fixed price targets. Traders may combine fundamentals with technical analysis to interpret this information. However, forecasts are often inaccurate and past performance is not a reliable indicator of future results.

Instead of relying on a single forecast, many traders monitor ongoing analysis and real-time data to respond to changing market conditions, including Recursion Pharmaceuticals, Inc. forecasts based on LSEG data.

How to trade Recursion Pharmaceuticals, Inc. share CFDs

Trading share CFDs does not involve purchasing or owning the underlying stock. Instead, you speculate on price direction using leveraged instruments:

• Go long (buy) if you expect the price of Recursion Pharmaceuticals, Inc. may rise
• Go short (sell) if you think the price may fall

CFDs allow magnified exposure through leverage, but leverage also magnifies losses, so it is important to manage risk carefully.

Risks of trading share CFDs

CFD trading carries a high level of risk and is not suitable for all investors. Key risks include:

• Market volatility: Prices can move quickly and unpredictably
• Leverage risk: Both profits and losses are amplified
• Funding costs: Overnight positions may incur adjustments
• No ownership: CFDs don’t provide shareholder rights or dividends

Before trading, consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.